VYGR
NASDAQ
$3.05
Voyager Therapeutics Inc (VYGR)
Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases. The company is headquartered in Cambridge, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $14.89 (+388.20%)
Market Cap
$193M
Free Cash Flow Yield
-67.33%
Beta (5Y)
1.41
Price Chart
Valuation
Market Cap$193M
Forward P/E8.44
P/S5.23
P/B1.10
Profitability
Total Revenue (TTM)$36M
Gross Profit (TTM)-$89M
EBITDA-$123M
Operating Margin-1167%
EPS-$2.03
Financial Health
Free Cash Flow Yield-67.33%
Growth & Risk
Revenue 5Y CAGR-25.55%
FCF 5Y CAGR+5.34%
Beta (5Y)1.41
Sharpe Ratio0.17